Information Provided By:
Fly News Breaks for February 13, 2017
BLRX
Feb 13, 2017 | 07:11 EDT
Rodman & Renshaw analyst Joseph Pantginis started BioLineRx with a Buy rating and $3 price target.
News For BLRX From the Last 2 Days
BLRX
Mar 28, 2024 | 10:59 EDT
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Altamira Therapeutics... To see the rest of the story go to thefly.com. See Story Here